Overview

Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD

Status:
Withdrawn
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To the best of our knowledge, there has been no randomized controlled trial to compare double dose PPI therapy with standard one dose PPI therapy for NERD patients. Thus, we hypothesize that a double dose PPI would accelerate and sustain the control of symptom in NERD patients.
Phase:
Phase 3
Details
Lead Sponsor:
Inje University
Treatments:
Rabeprazole